0001140361-22-026500 Sample Contracts

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • July 20th, 2022 • Immunocore Holdings PLC • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is made and entered into as of July 15, 2022 (the “Execution Date”) by and among Immunocore Holdings plc (registered number 13119746), a public limited company incorporated in England and Wales whose registered office is at 92 Park Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RY United Kingdom (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).

AutoNDA by SimpleDocs
Registration Rights Agreement
Registration Rights Agreement • July 20th, 2022 • Immunocore Holdings PLC • Biological products, (no disgnostic substances) • New York

This Registration Rights Agreement (this “Agreement”) is entered into as of July 15, 2022, by and among Immunocore Holdings plc, a public limited company incorporated in England and Wales with Company number 13119746 (the “Company”), and the investors listed on the attached Schedule A who are signatories to this Agreement (individually as an “Investor” and collectively, the “Investors”). Unless otherwise defined herein, capitalized terms used in this Agreement have the respective meanings ascribed to them in Section 1.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!